Loading…

Laboratoires Théa is constructing a new production facility near La Rochelle, France, to manufacture an ophthalmic insert for cataract treatment. The investment is about ten million euros, with the site expected to be operational in 2026, creating about 30 jobs and increasing production capacity by 20-30%.
“La surface de nos locaux sera multipliée par quatre, et nous pourrons répondre à une hausse de la demande de 20% à 30%.”lesechos.fr
Summarized from public sources; check the original articles before acting on it.